Latest News for: therapeutics initiative

Edit

FoRx Therapeutics Initiates First-in-Human Trial with Novel Anti-Cancer Drug FORX-428 Targeting DNA Damage Response

Pharmiweb 12 Aug 2025
Tarig Bashir, CEO of FoRx Therapeutics, said. “FoRx is built on the disruptive potential of PARG inhibition as a therapeutic strategy ... An initial data readout from the trial is expected by mid-2026.
Edit

Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First ...

Citizen Tribune 14 Jul 2025
First modules of BLA submitted to FDA under rolling ...
Edit

Nanoscope Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for MCO-010, the First Gene-Agnostic Therapy to Treat Retinitis Pigmentosa

PR Newswire 14 Jul 2025
DALLAS, July 14, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel gene-agnostic therapies for patients suffering severe ...
Edit

Avenzo Therapeutics Initiates Phase 1/2 Clinical Study of AVZO-023, a Potential Best-in-Class, Novel CDK4 Selective Inhibitor

Business Wire 05 Jun 2025
SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics Initiates Phase 1/2 Clinical Study of AVZO-023, a Potential Best-in-Class, Novel CDK4 Selective Inhibitor ... .
Edit

AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology

Nasdaq Globe Newswire 05 Jun 2025
Leuven, Belgium, June 5, 2025 – AstriVax Therapeutics NV, a ...
Edit

Acerand Therapeutics Initiates First-in-Human Phase I Clinical Trial of ACE-232, a Novel CYP11A1 Inhibitor for ...

The Joplin Globe 05 Jun 2025
SHANGHAI & INDIANAPOLIS--(BUSINESS WIRE)--Jun 4, 2025-- ... .
Edit

Avenzo Therapeutics Initiates Phase 1/2 Clinical Study of AVZO-1418, a Potential Best-in-Class, Novel EGFR/HER3 Bispecific ...

Business Wire 03 Jun 2025
SAN DIEGO--(BUSINESS WIRE)--Avenzo Therapeutics Initiates Phase 1/2 Clinical Study of AVZO-1418, a Potential Best-in-Class, Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate ... .
  • 1

Article Search

tools
×
×
×
×